#ExpertAnswers: Kosuke Minamihata and Jes Kuruvilla on Synthetic Peptides for Regenerative Medicine (Podcast)

Airdate: Friday, May 5, 2023 Season: 10 Episode: 11

Guests: Kosuke Minamihata, Jes Kuruvilla

In this episdoe of #ExpertAnswers, Dr. Kosuke Minamihata from PeptiGrowth and Dr. Jes Kuruvilla from MIFI Bioceuticals answer questions from a recent webinar showing how synthetic growth factors work and highlighting application examples using these synthetic peptides for cell therapy and regenerative medicine.

For more information or to watch the webinar, click here.

Associated Webinar: Synthetic Peptide Growth Factors: Forging the Path Forward for Regenerative Medicine, Cell Therapy, and Cellular Agriculture

You can listen to this podcast on:

Similar Podcasts

Industry Insights with Sino Biological: Cytokines – Catalysts of the Regenerative Revolution

Ritwika Biswas from Sino Biological explores the transformative potential of regenerative medicine and the crucial role of cytokines in tissue repair and regeneration.

#ExpertAnswers: Jack Vanden Heuvel on Nuclear Receptor Profiling

Dr. Jack Vanden Heuvel from Penn State University answers questions from a recent webinar discussing the use of cell-based reporter assays for nuclear receptor profiling to efficiently prioritize drug candidates and minimize off-target effects. For more information or to watch the webinar, click here.

#ExpertAnswers: Steven Loo-Yong-Kee on CRISPR-Edited T Cells

Steven Loo-Yong-Kee highlights Artisan Bio’s STAR-CRISPR system for optimized gene editing in cell therapy, with a focus on the genetic modification of T cells for cancer immunotherapy.

Related Content

Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment

In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.

Cut and Paste of Myosin Binding Protein-C in Striated Muscles

Dr. Samantha Harris discusses the development of three new mouse models in her lab, engineered to target and replace specific myosin binding protein-C paralogs in muscle fibers and impact of their mutations on skeletal and cardiac muscle diseases.